Minimally invasive system for baroreflex activation therapy chronically lowers blood pressure with pacemaker-like safety profile: results from the Barostim neo trial

Uta C. Hoppe*, Mathias-Christoph Brandt, Rolf Wachter, Joachim Beige, Lars Christian Rump, Abraham A. Kroon, Adam W. Cates, Eric G. Lovett, Hermann Haller

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

168 Citations (Web of Science)
Original languageEnglish
Pages (from-to)270-276
JournalJournal of the American Society of Hypertension
Issue number4
Publication statusPublished - 2012


  • Baroreflex
  • medical device
  • resistant hypertension

Cite this